A randomized trial of therapies for type 2 diabetes and coronary artery disease - Wikidata - wikimedia - TriplyDB

A randomized trial of therapies for type 2 diabetes and coronary artery disease

A randomized trial of therapies for type 2 diabetes and coronary artery disease

http://www.wikidata.org/entity/Q33827504

about

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD - Summary Sulphonylurea monotherapy for patients with type 2 diabetes mellitus Sulphonylurea monotherapy for patients with type 2 diabetes mellitus Standards of medical care in diabetes--2012 Imaging Atherosclerosis.New Insights in the Diagnosis and Treatment of Heart Failure Quantitative myocardial blood flow with Rubidium-82 PET: a clinical perspective Vascular repair strategies in type 2 diabetes: novel insights An Overview of Meta-Analyses of Danhong Injection for Unstable Angina Type 2 diabetes mellitus development programs in the new regulatory environment with cardiovascular safety requirements Coronary artery revascularization in patients with diabetes mellitus Comparative definitions for moderate-severe ischemia in stress nuclear, echocardiography, and magnetic resonance imaging Computed fractional flow reserve (FFTCT) derived from coronary CT angiography Clinical review: Screening for coronary artery disease in type 2 diabetes.Insulin resistance as a physiological defense against metabolic stress: implications for the management of subsets of type 2 diabetes Cardiovascular importance of hyperglycemia and hypoglycemia Early diabetic nephropathy in type 1 diabetes: new insights Should antidiabetic treatment of type 2 diabetes in patients with heart failure differ from that in patients without?Coronary revascularization in women Glycemic control and cardiovascular disease: what's a doctor to do?PPAR-γ as a therapeutic target in cardiovascular disease: evidence and uncertainty Current perspectives on cardiovascular outcome trials in diabetes Screening for asymptomatic coronary artery disease in patients with diabetes mellitus: A systematic review and meta-analysis of randomized trials Strategies for Diabetes Management: Using Newer Oral Combination Therapies Early in the Disease Update on pre-diabetes: Focus on diagnostic criteria and cardiovascular risk Identification of coronary heart disease in asymptomatic individuals with diabetes mellitus: to screen or not to screen Peroxisome proliferator-activated receptor-gamma agonists suppress tissue factor overexpression in rat balloon injury model with paclitaxel infusion Standards of medical care in diabetes--2013 Management standards for stable coronary artery disease in India.Comprehensive Cardiovascular Risk Reduction and Cardiac Rehabilitation in Diabetes and the Metabolic Syndrome.Value of Exercise ECG for Risk Stratification in Suspected or Known CAD in the Era of Advanced Imaging Technologies [National disease management guidelines (NVL) for chronic CAD : What is new, what is particularly important?].Assessment of stable coronary artery disease by cardiovascular magnetic resonance imaging: Current and emerging techniques.Triglyceride High-Density Lipoprotein Ratios Predict Glycemia-Lowering in Response to Insulin Sensitizing Drugs in Type 2 Diabetes: A Post Hoc Analysis of the BARI 2D.Relationships of obesity and fat distribution with atherothrombotic risk factors: baseline results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial.Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: results from the Bypass Angioplasty Revascu Prevalence and predictors of ischemia and outcomes in outpatients with diabetes mellitus referred for single-photon emission computed tomography myocardial perfusion imaging.Sub-optimal achievement of guideline-derived lipid goals in management of diabetes patients with atherosclerotic cardiovascular disease, despite high use of evidence-based therapies.Chronic coronary artery disease: diagnosis and management Tree-based identification of subgroups for time-varying covariate survival data.

P2860

Q22241786-87392923-03D6-4EFA-8C21-35DB153C552C Q24186660-C261F715-EE0C-435B-92AC-0878BE7A75A3 Q24197884-591B5779-618D-4F1A-B48C-52CDA39B0F07 Q24632533-FE03A139-060A-42CB-ACE9-198211C7D730 Q26764836-0830D942-A24E-416D-836B-D58B3C0DB833 Q26774884-8ACAA7FA-F380-4E36-A3D0-3506EC636781 Q26778455-850E1CC9-1D8F-49FF-8C98-626F60246A85 Q26778658-F1119577-8AF0-4934-8C45-451131C74D19 Q26779380-7FAD429A-A941-42E6-ADF9-EB2D6FBD7F75 Q26801121-4090A09D-FE6D-4AF7-BD64-6A3F64555E19 Q26824002-7669E38D-A728-4722-8D3B-8B95F18FAC13 Q26827495-40616CAE-724E-4608-A636-35C940B6AB57 Q26859609-C1B06B4B-8D61-48DD-A4B8-B45AAB184FDE Q26860716-5E107146-BBFD-414A-8824-3FCBBD5E48AB Q26866924-F1E38E2D-D97A-4E08-89E3-290D620EF6D4 Q26999390-1664CF7E-FFF3-476F-AB10-22D8049E62AB Q27021632-505BE1F3-37AE-4D47-BA8D-D433F8780A1A Q27022813-04DDB91F-8C9C-4122-82E5-A02A25C98A16 Q27024151-C6427F65-2B04-40AB-A185-FF9EEAFB91BD Q27024469-D60E4B2C-16D4-4FD7-8527-5C5E42CD0FB0 Q27024799-F8C1081C-33E9-4FB7-BBFB-E6022F09D974 Q28066006-320F6294-A791-4B93-81E5-9B30BCD887BA Q28067628-6334DB75-F193-43C4-8305-7D3A56BBB34B Q28069065-3CF59600-B4D4-4815-B475-E59B7678FBAC Q28073749-E51311D4-EAC2-4485-8915-A2BFDD30B8BD Q28083730-7B5EF798-91E7-4B85-A671-65D820BA5969 Q28478187-B465C7A3-1BC4-40A0-A44D-895478E0E7C4 Q29620309-F4A72E7E-7D39-4707-9124-51E1D9B53847 Q30239853-71D44B0B-60FB-4DFE-958A-7348FDA4C96B Q30244968-2DDA312C-1546-440A-969F-C84E534BD88B Q30278097-2B8824F8-41CA-485B-87FC-6E6E6691FD5B Q30313892-3BAACB49-DBD4-494C-8C4C-34963E48F3E9 Q30361261-91857509-3A4E-4448-976D-942BE514AD15 Q30384663-0FC4C9E4-25C4-4EB3-B8BB-65004192FD63 Q30405237-73C5A119-3B63-4EE4-9CDC-6A33861A7517 Q30411237-909520AE-4B72-43CC-B4F0-68F39F0F2FB4 Q30413284-B7C6E9DF-8F60-43B6-9AB2-F570495812C0 Q30454904-C7CF3364-B5CE-4640-862E-EB6BC2AA580B Q30492121-D046A98E-01BB-4712-ABD2-3C0916092A2C Q30573568-BF3A4092-789B-491B-80B9-B4BCFB959C0B

P2860

A randomized trial of therapies for type 2 diabetes and coronary artery disease

http://www.wikidata.org/entity/Q33827504

description

2009 nî lūn-bûn

@nan

2009 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

A randomized trial of therapies for type 2 diabetes and coronary artery disease

@ast

A randomized trial of therapies for type 2 diabetes and coronary artery disease

@en

type

label

A randomized trial of therapies for type 2 diabetes and coronary artery disease

@ast

A randomized trial of therapies for type 2 diabetes and coronary artery disease

@en

prefLabel

A randomized trial of therapies for type 2 diabetes and coronary artery disease

@ast

A randomized trial of therapies for type 2 diabetes and coronary artery disease

@en

P1433

Q33827504-ED8BD3D9-00AB-4B47-BFC3-316A02DB2D9C

P1476

Q33827504-C81B48D9-B19C-426F-AA87-31FFB55FF9E0

P2093

Q33827504-0167C406-FBBE-4E38-A19B-059F6AA23FC5

Q33827504-16D6DF44-E359-417F-A5D6-C3617FC899F5

Q33827504-19FD1993-1DAD-4A90-A2D8-05F8EE111AC2

Q33827504-1A136F41-512F-43F7-962A-C1CBDFF5F18F

Q33827504-1A1942E3-A9E1-4F16-948A-C8DADCA121D2

Q33827504-3A92671A-9139-4877-9D5F-988C6322959C

Q33827504-4D7572FE-4458-4EE0-9658-D64876CCE5E4

Q33827504-5C9E69C2-E185-4DE3-8A90-C214002A8666

Q33827504-68F8F132-6821-4424-B5B2-47D70CA2EF1D

Q33827504-6BFDAF13-C2F0-4A5C-80C1-D1695B7AD7E0

P2860

Q33827504-056109E0-8D82-4B38-B7E0-073F1459DC7E

Q33827504-21DCF589-AEDA-4E4E-8771-8EB6E69CDD3B

Q33827504-3269CBFA-5E6E-4845-BAC5-CDDDADABA2F9

Q33827504-44D83A16-4C5A-4D4D-96DD-6363F2EDE258

Q33827504-4A7AF8FA-09CF-4176-A04E-1A0637E5CC33

Q33827504-4BA4870A-44A1-4F95-8003-04E7ED0D6B39

Q33827504-521C10CC-21CF-48D3-A9DC-69DA40F5342D

Q33827504-5D43BCDE-DE98-45C2-8A69-9F366F599B43

Q33827504-6408EEB5-2854-4620-9579-642C2C2A7B69

Q33827504-684B5699-2577-4DBC-A972-EECA526EF1EB

P304

Q33827504-E7353450-5DD4-413B-8317-D8479059674D

P31

Q33827504-44CF586A-C66B-45DD-966B-E0EA2B234E1C

P356

Q33827504-AE55CD04-9203-44AC-9040-F0DB4021ECC8

P407

Q33827504-1DAAACDA-5497-44BC-9AFE-AA57FD275E64

P433

Q33827504-23D886F4-6A6F-4964-B266-7E8F80E90EFF

P478

Q33827504-28624087-B65E-4E21-B6C4-6FF2FD3A4E92

P50

Q33827504-B703EFC2-DD92-41A4-8A46-9D799A40E91D

Q33827504-C71B442D-CD4D-4917-BEF4-F112BD02CAC6

Q33827504-EF6B6E52-53FC-47A2-A143-0FC1C9ACC6C9

P577

Q33827504-EA3AEB00-6870-4244-8E45-4AC5A5B0FEAE

P698

Q33827504-3A067058-E6A1-40D4-8D43-A38315C30A1D

P921

Q33827504-DEF9C1D1-7444-44EE-9207-A6C2CF513D47

P932

Q33827504-6435E014-C344-48CF-BFF6-A0B694B212E7

P356

P1433

The New England Journal of Medicine

P1476

A randomized trial of therapies for type 2 diabetes and coronary artery disease

@en

P2093

BARI 2D Study Group

http://www.w3.org/2001/XMLSchema#string

Bernard R Chaitman

http://www.w3.org/2001/XMLSchema#string

Burton E Sobel

http://www.w3.org/2001/XMLSchema#string

Edward Y Sako

http://www.w3.org/2001/XMLSchema#string

Joan M MacGregor

http://www.w3.org/2001/XMLSchema#string

Mark E Molitch

http://www.w3.org/2001/XMLSchema#string

Phyllis August

http://www.w3.org/2001/XMLSchema#string

Regina M Hardison

http://www.w3.org/2001/XMLSchema#string

Richard W Nesto

http://www.w3.org/2001/XMLSchema#string

Robert L Frye

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes

Treatment of cardiac risk factors in diabetic patients: How well do we follow the guidelines?

Control of cardiovascular risk factors in patients with diabetes and hypertension at urban academic medical centers

Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators

Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group

Banting lecture 1988. Role of insulin resistance in human disease

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes

Effects of intensive glucose lowering in type 2 diabetes

Glucose control and vascular complications in veterans with type 2 diabetes

Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial

P304

2503-2515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA0805796

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

360

http://www.w3.org/2001/XMLSchema#string

P50

Trevor J. Orchard

Maria M. Brooks

P577

2009-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19502645

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2863990

http://www.w3.org/2001/XMLSchema#string